BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2493532)

  • 1. Production of protease inhibitors by postsurgical macrophages.
    Fukasawa M; Campeau JD; Girgis W; Bryant SM; Rodgers KE; DiZerega GS
    J Surg Res; 1989 Mar; 46(3):256-61. PubMed ID: 2493532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of postsurgical macrophage function by early postsurgical polymorphonuclear leukocytes.
    Kuraoka S; Campeau JD; Nakamura RM; diZerega GS
    J Surg Res; 1992 Sep; 53(3):245-50. PubMed ID: 1326682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential secretion of plasminogen activator activity by postsurgical activated macrophages.
    Orita H; Campeau JD; Gale JA; Nakamura RM; diZerega GS
    J Surg Res; 1986 Dec; 41(6):569-73. PubMed ID: 3784540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A role of postsurgical macrophage activation by peritoneal injury].
    Fukasawa M; Orita H; Shimanuki T; Washio M; DiZerega GS
    Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):374-80. PubMed ID: 1651444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modulation of postsurgical macrophage function by postsurgical polymorphonuclear leukocytes].
    Kuraoka S; Washio M; DiZerega GS
    Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):363-8. PubMed ID: 1318494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo administration of tolmetin in hyaluronic acid modulates protease levels in postsurgical macrophage-conditioned media.
    Rodgers KE; Abe H; Campeau JD; Ellefson DD; Girgis W; diZerega GS
    J Invest Surg; 1992; 5(4):285-96. PubMed ID: 1472482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interleukin-1 (IL-1) on postsurgical macrophage secretion of protease and protease inhibitor activities.
    Kuraoka S; Campeau JD; Rodgers KE; Nakamura RM; diZerega GS
    J Surg Res; 1992 Jan; 52(1):71-8. PubMed ID: 1312652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hemostatic effect of deacetylated chitin membrane on peritoneal injury in rabbit model.
    Fukasawa M; Abe H; Masaoka T; Orita H; Horikawa H; Campeau JD; Washio M
    Surg Today; 1992; 22(4):333-8. PubMed ID: 1392345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease and protease inhibitor secretion by postsurgical macrophages following in vitro exposure to tolmetin.
    Rodgers KE; Ellefson D; Girgis W; diZerega GS
    Agents Actions; 1992 Jul; 36(3-4):248-57. PubMed ID: 1326879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatoma cell line plasminogen activator.
    Levin EG; Fair DS; Loskutoff DJ
    J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    Chapman HA; Stone OL; Vavrin Z
    J Clin Invest; 1984 Mar; 73(3):806-15. PubMed ID: 6368589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator production by bovine milk macrophages and blood monocytes.
    Politis I; Zhao X; McBride BW; Burton JH; Turner JD
    Am J Vet Res; 1991 Aug; 52(8):1208-13. PubMed ID: 1928901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60.
    Alving BM; Krishnamurti C; Liu YP; Lucas DL; Wright DG
    Thromb Res; 1988 Jul; 51(2):175-85. PubMed ID: 3142093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions.
    Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
    Ann Otol Rhinol Laryngol; 1985; 94(3):293-6. PubMed ID: 3925865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
    Laug WE
    Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of fibroblast proliferation by postsurgical macrophages.
    Fukasawa M; Bryant SM; Nakamura RM; diZerega GS
    J Surg Res; 1987 Dec; 43(6):513-20. PubMed ID: 3695452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cytotoxic activity of resident macrophages by postsurgical macrophages.
    Kuraoka S; Campeau JD; Rodgers KE; Nakamura RM; diZerega GS
    J Surg Res; 1993 Oct; 55(4):397-403. PubMed ID: 8412126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of interleukin-1 and tumor necrosis factor secretion by rabbit macrophages recovered from the peritoneal cavity after surgery.
    Abe H; Rodgers KE; Ellefson D; diZerega GS
    J Invest Surg; 1991; 4(2):141-51. PubMed ID: 2069924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of plasminogen activator inhibitor by cultured human epidermal cells.
    Hashimoto K; Nishioka K; Katayama I; Yoshikawa K
    Br J Dermatol; 1986 Aug; 115(2):133-8. PubMed ID: 3091060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.